Bookmark
Forward
Explore Literature Results
QuickView for TNRC13;jsessionid=3D765BD25ABDC6EF1EDE0A75B9F1BD6C;jsessionid=84A7B1B8F90E10C4BB8EF198E8862C87;jsessionid=086624F9ED561E2247AC960DF604F403;jsessionid=D6CE45891B758B23072D12349DA813EB;jsessionid=A78ED1FEEC9A13DD17CCC8E3368A4B4D;jsessionid=47392097A808ED62D9A59C2FF2E1F237;jsessionid=AF24B6ABE41D1E0332BF40099E33C995;jsessionid=6DDF4159FC55C0AB4734AF9B40A5BABF (gene)
Most Relevant Literature
- Ataxin-2 sequesters Raptor into aggregates and impairs cellular mTORC1 signaling.
- ATXN2 is a target of N-terminal proteolysis.
- ATXN2 intermediate expansions in amyotrophic lateral sclerosis.
- TDP-43 impairs sleep in Drosophila through Ataxin-2-dependent metabolic disturbance.
- Missense mutation in ATXN2 gene (c.2860C > T) in an amyotrophic lateral sclerosis patient with aggre…
Most Relevant Clinical Trials
There were no clinical trials for TNRC13;jsessionid=3D765BD25ABDC6EF1EDE0A75B9F1BD6C;jsessionid=84A7B1B8F90E10C4BB8EF198E8862C87;jsessionid=086624F9ED561E2247AC960DF604F403;jsessionid=D6CE45891B758B23072D12349DA813EB;jsessionid=A78ED1FEEC9A13DD17CCC8E3368A4B4D;jsessionid=47392097A808ED62D9A59C2FF2E1F237;jsessionid=AF24B6ABE41D1E0332BF40099E33C995;jsessionid=6DDF4159FC55C0AB4734AF9B40A5BABF
Explore Clinical Trials Results
